Science

Joaquim Bellmunt: Predicting immunotherapy response of advanced bladder cancer through a meta-analysis of six independent cohorts

Hospital del Mar/X

Feb 25, 2025, 08:46

Joaquim Bellmunt: Predicting immunotherapy response of advanced bladder cancer through a meta-analysis of six independent cohorts

Joaquim Bellmunt, Medical oncologist at Harvard Medical School, shared a post on X about a paper he co-authored with colleagues published in Nature Communications:

“Our paper ‘Predicting immunotherapy response of advanced bladder cancer through a meta-analysis of six independent cohorts’ is out today at Nature Communications. Data of 707 advanced bladder cancer pts treated with anti-PD-1/anti-PD-L1 to build highly accurate predictive models.”

“Predicting immunotherapy response of advanced bladder cancer through a meta-analysis of six independent cohorts”

Authors: Lilian Marie Boll, Sergio Vázquez Montes de Oca, Marta Camarena, Robert Castelo, Joaquim Bellmunt, Júlia Perera-Bel, Mar Albà.

More posts featuring Joaquim Bellmunt.

advanced bladder cancer cancer immunotherapy Joaquim Bellmunt Júlia Perera-Bel Lilian Marie Boll Mar Albà Marta Camarena OncoDaily Oncology Robert Castelo Sergio Vázquez Montes de Oca

Top 10 Oncogrants of the Week: Advancing Breakthroughs in Cancer Care

Solange Peters Honored with the IASLC Paul A. Bunn, Jr. Scientific Award 2025

World Radiotherapy Awareness Day, September 7: Recognizing the Hidden Hero of Cancer Care

16 Posts Not to Miss From WCLC 2025 Part 1

Aparna Parikh Has Been Named Program Director for the GI Medical Oncology Program at Mass General Brigham